Izvoz spreman — 

Phase II study of high-dose dexamethasone-based association in acute and delayed high-dose cisplatin-induced emesis--JCOG study 9413.

Thirty-three patients with lung cancer receiving 80 mg m(-2) cisplatin were treated with high-dose dexamethasone (32 mg m(-2) on days 1-3, 16 mg m(-2) on day 4 and 8 mg m(-2) on day 5) combined with granisetron on day 1 and metoclopramide on days 2-5. Twenty-eight (85%) patients had no nausea or vom...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Sekine, I., Nishiwaki, Y., Kakinuma, R., Kubota, K., Hojo, F., Matsumoto, T., Ohmatsu, H., Yokozaki, M., Goto, K., Miyamoto, T., Takafuji, J., Kodama, T.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 1997
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2223781/
https://ncbi.nlm.nih.gov/pubmed/9218738
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items